# Endometriosis: Immunomodulation

> **NCT01184144** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Wisconsin, Madison**

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT01184144
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01184144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01184144, "Endometriosis: Immunomodulation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01184144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*